The Application Notebook
An effective UHPLC–MS method for high throughput separation, identification and quantification of pseudoephedrine was developed on a Hypersil GOLD PFP 1.9 µm, 2.1 Ã- 100 mm column.
Guifeng Jiang, Ray Chen and Chris Loran, Thermo Fisher Scientific Inc., San Jose, California, USA.
An effective UHPLC–MS method for high throughput separation, identification and quantification of pseudoephedrine was developed on a Hypersil GOLD PFP 1.9 µm, 2.1 × 100 mm column.
Pseudoephedrine and ephedrine are highly coveted by drug traffickers who use them to manufacture methamphetamine, for the illicit market.1 The separation and identification of pseudoephedrine from illicit drug mixtures, especially the methamphetamine group compounds, will help to identify the sources and the manufacture pathway of the methamphetamine seized in the illicit market.
We report separation, identification and quantification of pseudoephedrine in a mixture of five illicit drugs/metabolites by ultra high performance liquid chromatography–mass spectrometry (UHPLC–MS).
Instrument: Thermo Scientific Accela UHPLC system Thermo Scientific MSQ Plus
Column: Hypersil GOLD PFP 1.9 µm, 100 × 2.1 mm
Flow-rate: 1 mL/min
Mobile phase: A: Water with 0.06 % acetic acid B: Acetonitrile (ACN) with 0.06% acetic acid
Gradient:
Injection volume: 1 mL partial loop injection, 25 mL loop size
Column temperature: 45 °C
Ionization: Electrospray (ESI)
Probe temperature: 450 °C
Cone voltage: 55.0 V
Scan mode: Full scan with mass range of 100–200 m/z
ESI voltage: 4.5 kV
Pseudoephedrine was identified as the major active ingredient for all the three brand name drugs by UHPLC–MS method (Figure 1). The peak retention time of 2.62 min for all three samples matched very well with the retention time of the pseudoephedrine standard at 2.60 min. The confirmation of pseudoephedrine at 2.6 min was further assured by the match of the MS spectra of the three samples with the pseudoephedrine standard.
An internal standard method was used for the quantitative determination of pseudoephedrine in its tablet form. The concentration of the assay samples determined (120.09 ppb) were in good agreement with the reported values (120 ppb).
Figure 1
A simple, fast and reliable separation and identification method for five drugs (pseudoephedrine, ephedrine, amphetamine, methamphetamine and 3,4-MDMA) using UHPLC–MS is developed. The ppb (ng/mL) level sensitivity and accuracy by this method are more than sufficient to identify and quantify pseudoephedrine and/or other components in the seized illicit drug samples.
1. Pseudoephedrine Notice, Office of Division Control, US Department of Justice, Drug Enforcement Administration.
Thermo Fisher Scientific Inc.
355 River Oaks Parkway, San Jose, California 95134-1991, USA
tel. +1 800 532 4752 fax +1 561 688 8731
Website: www.thermo.com
New Method Explored for the Detection of CECs in Crops Irrigated with Contaminated Water
April 30th 2025This new study presents a validated QuEChERS–LC-MS/MS method for detecting eight persistent, mobile, and toxic substances in escarole, tomatoes, and tomato leaves irrigated with contaminated water.
University of Tasmania Researchers Explore Haloacetic Acid Determiniation in Water with capLC–MS
April 29th 2025Haloacetic acid detection has become important when analyzing drinking and swimming pool water. University of Tasmania researchers have begun applying capillary liquid chromatography as a means of detecting these substances.
Prioritizing Non-Target Screening in LC–HRMS Environmental Sample Analysis
April 28th 2025When analyzing samples using liquid chromatography–high-resolution mass spectrometry, there are various ways the processes can be improved. Researchers created new methods for prioritizing these strategies.
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.